Kenya National Cancer Control Programme (NCCP) FHIR Implementation Guide
0.1.0 - ci-build Kenya flag

Kenya National Cancer Control Programme (NCCP) FHIR Implementation Guide, published by Digital Health Agency (DHA), Kenya. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/IntelliSOFT-Consulting/nccpFHIRIG/ and changes regularly. See the Directory of published versions

: Kenya Oncology Condition (ICD-10) Code System

Active as of 2026-06-04

Raw ttl | Download


@prefix fhir: <http://hl7.org/fhir/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

# - resource -------------------------------------------------------------------

 a fhir:CodeSystem ;
  fhir:nodeRole fhir:treeRoot ;
  fhir:id [ fhir:v "condition-codes-cs"] ; # 
  fhir:language [ fhir:v "en"] ; # 
  fhir:text [
fhir:status [ fhir:v "generated" ] ;
fhir:div [ fhir:v "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: CodeSystem condition-codes-cs</b></p><a name=\"condition-codes-cs\"> </a><a name=\"hccondition-codes-cs\"> </a><p>This case-sensitive code system <code>https://nshr-uat.sha.go.ke/fhir/CodeSystem/condition-codes-cs</code> defines the following codes:</p><table class=\"codes\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td></tr><tr><td style=\"white-space:nowrap\">C50<a name=\"condition-codes-cs-C50\"> </a></td><td>C50 — Malignant neoplasm of breast</td></tr><tr><td style=\"white-space:nowrap\">C53<a name=\"condition-codes-cs-C53\"> </a></td><td>C53 — Malignant neoplasm of cervix uteri</td></tr><tr><td style=\"white-space:nowrap\">C54<a name=\"condition-codes-cs-C54\"> </a></td><td>C54 — Malignant neoplasm of corpus uteri</td></tr><tr><td style=\"white-space:nowrap\">C55<a name=\"condition-codes-cs-C55\"> </a></td><td>C55 — Malignant neoplasm of uterus, part unspecified</td></tr><tr><td style=\"white-space:nowrap\">C56<a name=\"condition-codes-cs-C56\"> </a></td><td>C56 — Malignant neoplasm of ovary</td></tr><tr><td style=\"white-space:nowrap\">C61<a name=\"condition-codes-cs-C61\"> </a></td><td>C61 — Malignant neoplasm of prostate</td></tr><tr><td style=\"white-space:nowrap\">C18<a name=\"condition-codes-cs-C18\"> </a></td><td>C18 — Malignant neoplasm of colon</td></tr><tr><td style=\"white-space:nowrap\">C19<a name=\"condition-codes-cs-C19\"> </a></td><td>C19 — Malignant neoplasm of rectosigmoid junction</td></tr><tr><td style=\"white-space:nowrap\">C20<a name=\"condition-codes-cs-C20\"> </a></td><td>C20 — Malignant neoplasm of rectum</td></tr><tr><td style=\"white-space:nowrap\">C15<a name=\"condition-codes-cs-C15\"> </a></td><td>C15 — Malignant neoplasm of oesophagus</td></tr><tr><td style=\"white-space:nowrap\">C16<a name=\"condition-codes-cs-C16\"> </a></td><td>C16 — Malignant neoplasm of stomach</td></tr><tr><td style=\"white-space:nowrap\">C22<a name=\"condition-codes-cs-C22\"> </a></td><td>C22 — Malignant neoplasm of liver and intrahepatic bile ducts</td></tr><tr><td style=\"white-space:nowrap\">C25<a name=\"condition-codes-cs-C25\"> </a></td><td>C25 — Malignant neoplasm of pancreas</td></tr><tr><td style=\"white-space:nowrap\">C34<a name=\"condition-codes-cs-C34\"> </a></td><td>C34 — Malignant neoplasm of bronchus and lung</td></tr><tr><td style=\"white-space:nowrap\">C32<a name=\"condition-codes-cs-C32\"> </a></td><td>C32 — Malignant neoplasm of larynx</td></tr><tr><td style=\"white-space:nowrap\">C11<a name=\"condition-codes-cs-C11\"> </a></td><td>C11 — Malignant neoplasm of nasopharynx</td></tr><tr><td style=\"white-space:nowrap\">C73<a name=\"condition-codes-cs-C73\"> </a></td><td>C73 — Malignant neoplasm of thyroid gland</td></tr><tr><td style=\"white-space:nowrap\">C64<a name=\"condition-codes-cs-C64\"> </a></td><td>C64 — Malignant neoplasm of kidney, except renal pelvis</td></tr><tr><td style=\"white-space:nowrap\">C67<a name=\"condition-codes-cs-C67\"> </a></td><td>C67 — Malignant neoplasm of bladder</td></tr><tr><td style=\"white-space:nowrap\">C43<a name=\"condition-codes-cs-C43\"> </a></td><td>C43 — Malignant melanoma of skin</td></tr><tr><td style=\"white-space:nowrap\">C71<a name=\"condition-codes-cs-C71\"> </a></td><td>C71 — Malignant neoplasm of brain</td></tr><tr><td style=\"white-space:nowrap\">C40<a name=\"condition-codes-cs-C40\"> </a></td><td>C40 — Malignant neoplasm of bone and articular cartilage of limbs</td></tr><tr><td style=\"white-space:nowrap\">C49<a name=\"condition-codes-cs-C49\"> </a></td><td>C49 — Malignant neoplasm of connective and soft tissue</td></tr><tr><td style=\"white-space:nowrap\">C81<a name=\"condition-codes-cs-C81\"> </a></td><td>C81 — Hodgkin lymphoma</td></tr><tr><td style=\"white-space:nowrap\">C83<a name=\"condition-codes-cs-C83\"> </a></td><td>C83 — Non-follicular lymphoma (incl. Burkitt)</td></tr><tr><td style=\"white-space:nowrap\">C85<a name=\"condition-codes-cs-C85\"> </a></td><td>C85 — Other and unspecified types of non-Hodgkin lymphoma</td></tr><tr><td style=\"white-space:nowrap\">C90<a name=\"condition-codes-cs-C90\"> </a></td><td>C90 — Multiple myeloma and malignant plasma cell neoplasms</td></tr><tr><td style=\"white-space:nowrap\">C91<a name=\"condition-codes-cs-C91\"> </a></td><td>C91 — Lymphoid leukaemia</td></tr><tr><td style=\"white-space:nowrap\">C92<a name=\"condition-codes-cs-C92\"> </a></td><td>C92 — Myeloid leukaemia</td></tr><tr><td style=\"white-space:nowrap\">C46<a name=\"condition-codes-cs-C46\"> </a></td><td>C46 — Kaposi sarcoma</td></tr><tr><td style=\"white-space:nowrap\">C69<a name=\"condition-codes-cs-C69\"> </a></td><td>C69 — Malignant neoplasm of eye and adnexa (incl. retinoblastoma)</td></tr><tr><td style=\"white-space:nowrap\">D05<a name=\"condition-codes-cs-D05\"> </a></td><td>D05 — Carcinoma in situ of breast</td></tr><tr><td style=\"white-space:nowrap\">D06<a name=\"condition-codes-cs-D06\"> </a></td><td>D06 — Carcinoma in situ of cervix uteri</td></tr></table></div>"^^rdf:XMLLiteral ]
  ] ; # 
  fhir:url [
fhir:v "https://nshr-uat.sha.go.ke/fhir/CodeSystem/condition-codes-cs"^^xsd:anyURI ;
fhir:l <https://nshr-uat.sha.go.ke/fhir/CodeSystem/condition-codes-cs>
  ] ; # 
  fhir:version [ fhir:v "0.1.0"] ; # 
  fhir:name [ fhir:v "ConditionCodesCS"] ; # 
  fhir:title [ fhir:v "Kenya Oncology Condition (ICD-10) Code System"] ; # 
  fhir:status [ fhir:v "active"] ; # 
  fhir:experimental [ fhir:v false] ; # 
  fhir:date [ fhir:v "2026-06-04T14:49:30+00:00"^^xsd:dateTime] ; # 
  fhir:publisher [ fhir:v "Digital Health Agency (DHA), Kenya"] ; # 
  fhir:contact ( [
fhir:name [ fhir:v "Digital Health Agency (DHA), Kenya" ] ;
    ( fhir:telecom [
fhir:system [ fhir:v "url" ] ;
fhir:value [ fhir:v "https://dha.go.ke" ]     ] [
fhir:system [ fhir:v "email" ] ;
fhir:value [ fhir:v "info@dha.go.ke" ]     ] )
  ] [
fhir:name [ fhir:v "Digital Health Agency Kenya – FHIR Team" ] ;
    ( fhir:telecom [
fhir:system [ fhir:v "email" ] ;
fhir:value [ fhir:v "info@dha.go.ke" ] ;
fhir:use [ fhir:v "work" ]     ] [
fhir:system [ fhir:v "url" ] ;
fhir:value [ fhir:v "https://dha.go.ke" ] ;
fhir:use [ fhir:v "work" ]     ] )
  ] ) ; # 
  fhir:description [ fhir:v "ICD-10 diagnosis codes for the most common malignancies in Kenya."] ; # 
  fhir:jurisdiction ( [
    ( fhir:coding [
fhir:system [
fhir:v "urn:iso:std:iso:3166"^^xsd:anyURI ;
fhir:l <urn:iso:std:iso:3166>       ] ;
fhir:code [ fhir:v "KE" ] ;
fhir:display [ fhir:v "Kenya" ]     ] )
  ] ) ; # 
  fhir:caseSensitive [ fhir:v true] ; # 
  fhir:content [ fhir:v "complete"] ; # 
  fhir:count [ fhir:v "33"^^xsd:nonNegativeInteger] ; # 
  fhir:concept ( [
fhir:code [ fhir:v "C50" ] ;
fhir:display [ fhir:v "C50 — Malignant neoplasm of breast" ]
  ] [
fhir:code [ fhir:v "C53" ] ;
fhir:display [ fhir:v "C53 — Malignant neoplasm of cervix uteri" ]
  ] [
fhir:code [ fhir:v "C54" ] ;
fhir:display [ fhir:v "C54 — Malignant neoplasm of corpus uteri" ]
  ] [
fhir:code [ fhir:v "C55" ] ;
fhir:display [ fhir:v "C55 — Malignant neoplasm of uterus, part unspecified" ]
  ] [
fhir:code [ fhir:v "C56" ] ;
fhir:display [ fhir:v "C56 — Malignant neoplasm of ovary" ]
  ] [
fhir:code [ fhir:v "C61" ] ;
fhir:display [ fhir:v "C61 — Malignant neoplasm of prostate" ]
  ] [
fhir:code [ fhir:v "C18" ] ;
fhir:display [ fhir:v "C18 — Malignant neoplasm of colon" ]
  ] [
fhir:code [ fhir:v "C19" ] ;
fhir:display [ fhir:v "C19 — Malignant neoplasm of rectosigmoid junction" ]
  ] [
fhir:code [ fhir:v "C20" ] ;
fhir:display [ fhir:v "C20 — Malignant neoplasm of rectum" ]
  ] [
fhir:code [ fhir:v "C15" ] ;
fhir:display [ fhir:v "C15 — Malignant neoplasm of oesophagus" ]
  ] [
fhir:code [ fhir:v "C16" ] ;
fhir:display [ fhir:v "C16 — Malignant neoplasm of stomach" ]
  ] [
fhir:code [ fhir:v "C22" ] ;
fhir:display [ fhir:v "C22 — Malignant neoplasm of liver and intrahepatic bile ducts" ]
  ] [
fhir:code [ fhir:v "C25" ] ;
fhir:display [ fhir:v "C25 — Malignant neoplasm of pancreas" ]
  ] [
fhir:code [ fhir:v "C34" ] ;
fhir:display [ fhir:v "C34 — Malignant neoplasm of bronchus and lung" ]
  ] [
fhir:code [ fhir:v "C32" ] ;
fhir:display [ fhir:v "C32 — Malignant neoplasm of larynx" ]
  ] [
fhir:code [ fhir:v "C11" ] ;
fhir:display [ fhir:v "C11 — Malignant neoplasm of nasopharynx" ]
  ] [
fhir:code [ fhir:v "C73" ] ;
fhir:display [ fhir:v "C73 — Malignant neoplasm of thyroid gland" ]
  ] [
fhir:code [ fhir:v "C64" ] ;
fhir:display [ fhir:v "C64 — Malignant neoplasm of kidney, except renal pelvis" ]
  ] [
fhir:code [ fhir:v "C67" ] ;
fhir:display [ fhir:v "C67 — Malignant neoplasm of bladder" ]
  ] [
fhir:code [ fhir:v "C43" ] ;
fhir:display [ fhir:v "C43 — Malignant melanoma of skin" ]
  ] [
fhir:code [ fhir:v "C71" ] ;
fhir:display [ fhir:v "C71 — Malignant neoplasm of brain" ]
  ] [
fhir:code [ fhir:v "C40" ] ;
fhir:display [ fhir:v "C40 — Malignant neoplasm of bone and articular cartilage of limbs" ]
  ] [
fhir:code [ fhir:v "C49" ] ;
fhir:display [ fhir:v "C49 — Malignant neoplasm of connective and soft tissue" ]
  ] [
fhir:code [ fhir:v "C81" ] ;
fhir:display [ fhir:v "C81 — Hodgkin lymphoma" ]
  ] [
fhir:code [ fhir:v "C83" ] ;
fhir:display [ fhir:v "C83 — Non-follicular lymphoma (incl. Burkitt)" ]
  ] [
fhir:code [ fhir:v "C85" ] ;
fhir:display [ fhir:v "C85 — Other and unspecified types of non-Hodgkin lymphoma" ]
  ] [
fhir:code [ fhir:v "C90" ] ;
fhir:display [ fhir:v "C90 — Multiple myeloma and malignant plasma cell neoplasms" ]
  ] [
fhir:code [ fhir:v "C91" ] ;
fhir:display [ fhir:v "C91 — Lymphoid leukaemia" ]
  ] [
fhir:code [ fhir:v "C92" ] ;
fhir:display [ fhir:v "C92 — Myeloid leukaemia" ]
  ] [
fhir:code [ fhir:v "C46" ] ;
fhir:display [ fhir:v "C46 — Kaposi sarcoma" ]
  ] [
fhir:code [ fhir:v "C69" ] ;
fhir:display [ fhir:v "C69 — Malignant neoplasm of eye and adnexa (incl. retinoblastoma)" ]
  ] [
fhir:code [ fhir:v "D05" ] ;
fhir:display [ fhir:v "D05 — Carcinoma in situ of breast" ]
  ] [
fhir:code [ fhir:v "D06" ] ;
fhir:display [ fhir:v "D06 — Carcinoma in situ of cervix uteri" ]
  ] ) . #